Sec. 6501. Intelligence strategy to counter foreign adversary efforts to utilize biotechnologies in ways that threaten United States national security
393 words·~2 min read·
/bill/118/hr/5009/eah/section-6501·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In this section, the term appropriate committees of Congress means— the congressional intelligence committees; the Committee on Foreign Relations, the Committee on Homeland Security and Governmental Affairs, the Committee on Health, Education, Labor, and Pensions, the Committee on Commerce, Science, and Transportation, the Committee on Armed Services, and the Committee on Appropriations of the Senate; and the Committee on Foreign Affairs, the Committee on Homeland Security, the Committee on Energy and Commerce, the Committee on Armed Services, and the Committee on Appropriations of the House of Representatives.
It is the sense of Congress that as biotechnologies become increasingly important with regard to the national security interests of the United States, and with the addition of biotechnologies to the biosecurity mission of the National Counterproliferation and Biosecurity Center, the intelligence community must articulate and implement an intelligence strategy to identify and assess threats relating to biotechnologies. Not later than 120 days after the date of the enactment of this Act, the Director of National Intelligence shall, in coordination with the heads of such other elements of the intelligence community as the Director of National Intelligence considers appropriate, develop and submit to the appropriate committees of Congress a strategy to address threats relating to biotechnologies.
The strategy developed and submitted pursuant to paragraph
(1)shall include the following: Identification and assessment of threats associated with biotechnologies critical to the national security of the United States, including materials that involve a dependency on foreign adversary nations. A determination of how best to counter foreign adversary efforts to utilize biotechnologies that threaten the national security of the United States, including threats identified pursuant to paragraph (1). A plan to support efforts of other Federal departments and agencies to secure United States supply chains of the biotechnologies critical to the national security of the United States, by coordinating— across the intelligence community; the support provided by the intelligence community to other relevant Federal departments and agencies and policymakers; the engagement of the intelligence community with private sector entities, in coordination with other relevant Federal departments and agencies, as may be applicable; and how the intelligence community, in coordination with other relevant Federal departments and agencies, supports and coordinates comparative assessments of United States competitiveness in biotechnologies critical to national and economic security. Proposals for such legislative or administrative action as the Director considers necessary to support the strategy.